Sun Pharma Advanced Research Co. Ltd. Balance Sheet
Sun Pharma Advanced Research Co. Ltd.'s total assets for Q2 2026 were ₹3.22B, an increase of Infinity% from the previous quarter. IN:SPARC total liabilities were ₹6.67B for the fiscal quarter, a 207.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.